NYSE · Financial · Asset Management · USA
Hercules Capital Inc is a mid cap company (market value between $2 billion and $10 billion) in the Asset Management industry.
Hercules Capital is a specialty finance company that provides senior secured loans to venture capital-backed and institutional-backed companies in technology and life sciences industries. The company invests in structured debt and senior secured debt instruments across technology sub-sectors including software, semiconductors, and telecommunications, as well as life sciences companies in medical devices and bio-pharmaceuticals.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Hercules Capital Inc stock.
Undervalued: intrinsic value $23.54 per share, market price $15.63, margin of safety 33.6% (as of 2026-11-17).
Book value at 2.06x, the multiple a 15.7% return on equity justifies, blended with earnings, values the shares at $23.54; the price of $15.63 is 34% below that value.
All 137 Asset Management stocks
16 more in this industry show a wider margin of safety.
HTGC is undervalued (as of the 2026-11-17 close). Book value at 2.06x, the multiple a 15.7% return on equity justifies, blended with earnings, values the shares at $23.54; the price of $15.63 is 34% below that value.
$23.54 per share (as of the 2026-11-17 close), against a market price of $15.63. That is a margin of safety of 33.6%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.